![Andrew B. Cubitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew B. Cubitt
Corporate Officer/Principal presso
ATYR PHARMA, INC.
Profilo
Andrew B. Cubitt was the founder of AnaptysBio, Inc. since 2005, serving as Executive Director-Corporate Development from 2005 to 2009.
Dr. Cubitt is currently Vice President-External Scientific Alliances at aTyr Pharma, Inc. since 2011.
Former positions include Director-Intellectual Property at Ambit Biosciences Corp., Senior Manager-Technology & Intellectual Property at Aurora Biosciences Corp.
from 1996 to 2002, and Principal at X-Ceptor Therapeutics, Inc. from 2002 to 2013.
Education includes an undergraduate degree from the University of Birmingham conferred in 1984 and a doctorate from The University of Sheffield conferred in 1987.
Posizioni attive di Andrew B. Cubitt
| Società | Posizione | Inizio |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/09/2011 |
Precedenti posizioni note di Andrew B. Cubitt
| Società | Posizione | Fine |
|---|---|---|
| ANAPTYSBIO, INC. | Fondatore | 01/07/2009 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 01/01/2002 |
| AMBIT BIOSCIENCES CORP | Corporate Officer/Principal | - |
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Corporate Officer/Principal | - |
Formazione di Andrew B. Cubitt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
63
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
